Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Proparco on its EUR 23 million Secondary Offering of Voltalia shares Bryan, Garnier & Co acts as Sole Financial Advisor to IT services group Artemys and its founders on a minority LBO operation with Andera Partners Bryan, Garnier & Co acts as Sole Financial Advisor to Amplexor International on the disposal of its France-based digital document engineering business unit, Amplexor Business Services, to Hivest Capital Partners Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Abivax on its EUR 28 million Follow-on Offering Bryan, Garnier & Co acts as Joint Bookrunner to GenSight on its EUR 25 million Follow-on Offering Bryan, Garnier & Co acts as Joint Bookrunner to Targovax on its NOK 75 million Follow-on Offering Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to McPhy on a EUR 180m Follow-on Offering including Strategic Investments from Chart Industries and Technip Energies Bryan, Garnier & Co acts as Sole Financial Advisor to INNOTHERA Group on its acquisition of Gibaud Bryan, Garnier & Co acts as Sole Financial Advisor to Sword Group SE on the disposal of its French unit, Sword France, to Argos Wityu Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista (Euronext: ALEZV) on a contemplated take-private led by Eurazeo PME Bryan, Garnier & Co acts as Joint Bookrunner on Sensorion’s EUR 31 million Follow-on Offering with top tier US and European biotech specialists and institutional investors Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 78 million Follow-on Offering
